Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs AUROBINDO PHARMA - Comparison Results

ABBOTT INDIA     Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

AUROBINDO PHARMA 
   Change

Aurobindo Pharma is one of India's top 5 pharma companies in terms of turnover, and has presence in the generic and Active Pharmaceutical Ingredients (API) segments. The company's robust product portfolio is spread across 6 product areas, including a... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA AUROBINDO PHARMA ABBOTT INDIA/
AUROBINDO PHARMA
 
P/E (TTM) x 47.8 17.7 269.2% View Chart
P/BV x 15.6 3.8 406.4% View Chart
Dividend Yield % 0.4 0.3 160.7%  

Financials

 ABBOTT INDIA   AUROBINDO PHARMA
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-19
AUROBINDO PHARMA
Mar-19
ABBOTT INDIA/
AUROBINDO PHARMA
5-Yr Chart
Click to enlarge
High Rs8,834830 1,064.3%   
Low Rs5,458527 1,035.4%   
Sales per share (Unadj.) Rs1,731.1333.9 518.5%  
Earnings per share (Unadj.) Rs211.940.4 525.1%  
Cash flow per share (Unadj.) Rs219.951.8 424.8%  
Dividends per share (Unadj.) Rs65.002.50 2,600.0%  
Dividend yield (eoy) %0.90.4 246.9%  
Book value per share (Unadj.) Rs945.2237.1 398.7%  
Shares outstanding (eoy) m21.25585.91 3.6%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x4.12.0 203.1%   
Avg P/E ratio x33.716.8 200.5%  
P/CF ratio (eoy) x32.513.1 247.9%  
Price / Book Value ratio x7.62.9 264.1%  
Dividend payout %30.76.2 495.1%   
Avg Mkt Cap Rs m151,848397,569 38.2%   
No. of employees `0003.517.9 19.5%   
Total wages/salary Rs m4,35625,849 16.9%   
Avg. sales/employee Rs Th10,555.510,956.9 96.3%   
Avg. wages/employee Rs Th1,249.91,447.7 86.3%   
Avg. net profit/employee Rs Th1,292.21,324.3 97.6%   
INCOME DATA
Net Sales Rs m36,786195,636 18.8%  
Other income Rs m1,1331,553 72.9%   
Total revenues Rs m37,919197,189 19.2%   
Gross profit Rs m6,04739,519 15.3%  
Depreciation Rs m1696,680 2.5%   
Interest Rs m232,626 0.9%   
Profit before tax Rs m6,98931,767 22.0%   
Minority Interest Rs m027 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-881 0.0%   
Tax Rs m2,4857,269 34.2%   
Profit after tax Rs m4,50323,645 19.0%  
Gross profit margin %16.420.2 81.4%  
Effective tax rate %35.622.9 155.4%   
Net profit margin %12.212.1 101.3%  
BALANCE SHEET DATA
Current assets Rs m27,610153,645 18.0%   
Current liabilities Rs m8,569120,429 7.1%   
Net working cap to sales %51.817.0 304.9%  
Current ratio x3.21.3 252.6%  
Inventory Days Days60135 44.5%  
Debtors Days Days2764 43.0%  
Net fixed assets Rs m1,057103,909 1.0%   
Share capital Rs m213586 36.3%   
"Free" reserves Rs m19,873138,322 14.4%   
Net worth Rs m20,086138,908 14.5%   
Long term debt Rs m01,800 0.0%   
Total assets Rs m29,409264,544 11.1%  
Interest coverage x311.613.1 2,379.1%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.30.7 169.1%   
Return on assets %15.49.9 155.0%  
Return on equity %22.417.0 131.7%  
Return on capital %34.923.8 146.4%  
Exports to sales %049.6 0.0%   
Imports to sales %018.8 0.0%   
Exports (fob) Rs mNA97,091 0.0%   
Imports (cif) Rs mNA36,741 0.0%   
Fx inflow Rs m36997,316 0.4%   
Fx outflow Rs m4,91840,589 12.1%   
Net fx Rs m-4,54956,727 -8.0%   
CASH FLOW
From Operations Rs m4,99116,220 30.8%  
From Investments Rs m-2,570-28,768 8.9%  
From Financial Activity Rs m-1,42819,191 -7.4%  
Net Cashflow Rs m9936,656 14.9%  

Share Holding

Indian Promoters % 0.0 54.1 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 7.9 8.0 99.4%  
FIIs % 0.1 27.7 0.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.1 10.2 167.6%  
Shareholders   18,270 69,601 26.2%  
Pledged promoter(s) holding % 0.0 8.6 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   NATCO PHARMA  PANACEA BIOTECH  WOCKHARDT  GSK PHARMA  FRESENIUS KABI ONCO.  

Compare ABBOTT INDIA With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 470 Points Lower; Tata Motors & Tata Steel Fall 6%(Closing)

Indian share markets witnessed huge selling pressure today, in line with global equities and fell on to bearish territory.

Related Views on News

AUROBINDO PHARMA Announces Quarterly Results (1QFY21); Net Profit Up 25.6% (Quarterly Result Update)

Sep 15, 2020 | Updated on Sep 15, 2020

For the quarter ended June 2020, AUROBINDO PHARMA has posted a net profit of Rs 8 bn (up 25.6% YoY). Sales on the other hand came in at Rs 59 bn (up 8.8% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (1QFY21); Net Profit Up 54.2% (Quarterly Result Update)

Aug 18, 2020 | Updated on Aug 18, 2020

For the quarter ended June 2020, ABBOTT INDIA has posted a net profit of Rs 2 bn (up 54.2% YoY). Sales on the other hand came in at Rs 11 bn (up 6.5% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (4QFY20); Net Profit Down 2.0% (Quarterly Result Update)

Jun 9, 2020 | Updated on Jun 9, 2020

For the quarter ended March 2020, ABBOTT INDIA has posted a net profit of Rs 1 bn (down 2.0% YoY). Sales on the other hand came in at Rs 10 bn (up 6.1% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

AUROBINDO PHARMA Announces Quarterly Results (4QFY20); Net Profit Up 48.2% (Quarterly Result Update)

Jun 5, 2020 | Updated on Jun 5, 2020

For the quarter ended March 2020, AUROBINDO PHARMA has posted a net profit of Rs 9 bn (up 48.2% YoY). Sales on the other hand came in at Rs 62 bn (up 16.4% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (3QFY20); Net Profit Up 59.5% (Quarterly Result Update)

Feb 11, 2020 | Updated on Feb 11, 2020

For the quarter ended December 2019, ABBOTT INDIA has posted a net profit of Rs 2 bn (up 59.5% YoY). Sales on the other hand came in at Rs 11 bn (up 13.8% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

More Views on News

Most Popular

My Top Stock Recommendation for 2021 and Beyond(Profit Hunter)

Jan 5, 2021

My new guide will show you the huge potential in future proof businesses.

'Essential' Smallcap Stock Recommendations(Profit Hunter)

Jan 8, 2021

The smallcap rally has enough steam left in it. If you haven't joined yet, it is still not too late.

Is Nifty Forming a Top(Fast Profits Daily)

Jan 8, 2021

The charts are telling the bulls to be cautious.

Why Gold Hit Lower Circuit(Fast Profits Daily)

Jan 11, 2021

Were you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Jan 18, 2021 03:36 PM

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA 5-YR ANALYSIS

COMPARE ABBOTT INDIA WITH

MARKET STATS